Liquid biopsy of the CSF using NGS may provide more reliable information than liquid biopsy of peripheral blood regarding uncommon EGFR mutations in patients with NSCLC and leptomeningeal metastases, and this information can potentially be used to guide therapy with TKIs. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.